Try our Advanced Search for more refined results
April 07, 2003
GARBER, et al v. PHARMACIA CORP, et al
Case Number:
3:03-cv-01519
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
- Anselmi & Carvelli
- Cohn Lifland
- Denlea & Carton
- DLA Piper
- Kantrowitz Goldhamer
- Lite DePalma
- Manatt Phelps
- Norris McLaughlin
- O'Melveny & Myers
- Saiber LLC
- Squitieri & Fearon
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
October 09, 2012
Pfizer Inks $164M Settlement In Celebrex Securities Suit
Pfizer Inc. agreed Friday to pay $164 million to settle a certified securities fraud class action in New Jersey federal court alleging it made materially false statements about a clinical study of blockbuster anti-inflammatory drug Celebrex, ending a much-publicized case that was set for trial later this month.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login